Chemed Statistics
Total Valuation
Chemed has a market cap or net worth of $6.12 billion. The enterprise value is $6.34 billion.
| Market Cap | 6.12B |
| Enterprise Value | 6.34B |
Important Dates
The next estimated earnings date is Tuesday, July 28, 2026, after market close.
| Earnings Date | Jul 28, 2026 |
| Ex-Dividend Date | May 28, 2026 |
Share Statistics
Chemed has 13.22 million shares outstanding. The number of shares has decreased by -5.66% in one year.
| Current Share Class | 13.22M |
| Shares Outstanding | 13.22M |
| Shares Change (YoY) | -5.66% |
| Shares Change (QoQ) | -2.28% |
| Owned by Insiders (%) | 1.62% |
| Owned by Institutions (%) | 103.02% |
| Float | 12.99M |
Valuation Ratios
The trailing PE ratio is 25.32 and the forward PE ratio is 18.62. Chemed's PEG ratio is 1.56.
| PE Ratio | 25.32 |
| Forward PE | 18.62 |
| PS Ratio | 2.41 |
| Forward PS | 2.24 |
| PB Ratio | 7.22 |
| P/TBV Ratio | 76.48 |
| P/FCF Ratio | 16.24 |
| P/OCF Ratio | 13.80 |
| PEG Ratio | 1.56 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.06, with an EV/FCF ratio of 16.82.
| EV / Earnings | 24.42 |
| EV / Sales | 2.50 |
| EV / EBITDA | 16.06 |
| EV / EBIT | 19.01 |
| EV / FCF | 16.82 |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.28.
| Current Ratio | 0.85 |
| Quick Ratio | 0.72 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 0.51 |
| Debt / FCF | 0.63 |
| Interest Coverage | 172.62 |
Financial Efficiency
Return on equity (ROE) is 25.60% and return on invested capital (ROIC) is 23.47%.
| Return on Equity (ROE) | 25.60% |
| Return on Assets (ROA) | 12.79% |
| Return on Invested Capital (ROIC) | 23.47% |
| Return on Capital Employed (ROCE) | 27.48% |
| Weighted Average Cost of Capital (WACC) | 6.97% |
| Revenue Per Employee | $160,682 |
| Profits Per Employee | $16,431 |
| Employee Count | 15,811 |
| Asset Turnover | 1.56 |
| Inventory Turnover | 229.10 |
Taxes
In the past 12 months, Chemed has paid $89.16 million in taxes.
| Income Tax | 89.16M |
| Effective Tax Rate | 25.55% |
Stock Price Statistics
The stock price has decreased by -16.15% in the last 52 weeks. The beta is 0.54, so Chemed's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | -16.15% |
| 50-Day Moving Average | 425.90 |
| 200-Day Moving Average | 429.61 |
| Relative Strength Index (RSI) | 69.75 |
| Average Volume (20 Days) | 231,674 |
Short Selling Information
The latest short interest is 637,297, so 4.82% of the outstanding shares have been sold short.
| Short Interest | 637,297 |
| Short Previous Month | 525,042 |
| Short % of Shares Out | 4.82% |
| Short % of Float | 4.91% |
| Short Ratio (days to cover) | 2.90 |
Income Statement
In the last 12 months, Chemed had revenue of $2.54 billion and earned $259.78 million in profits. Earnings per share was $18.30.
| Revenue | 2.54B |
| Gross Profit | 822.54M |
| Operating Income | 333.68M |
| Pretax Income | 348.94M |
| Net Income | 259.78M |
| EBITDA | 395.07M |
| EBIT | 333.68M |
| Earnings Per Share (EPS) | $18.30 |
Balance Sheet
The company has $16.86 million in cash and $236.93 million in debt, giving a net cash position of -$220.08 million or -$16.65 per share.
| Cash & Cash Equivalents | 16.86M |
| Total Debt | 236.93M |
| Net Cash | -220.08M |
| Net Cash Per Share | -$16.65 |
| Equity (Book Value) | 847.99M |
| Book Value Per Share | 64.15 |
| Working Capital | -47.35M |
Cash Flow
In the last 12 months, operating cash flow was $443.75 million and capital expenditures -$66.63 million, giving a free cash flow of $377.12 million.
| Operating Cash Flow | 443.75M |
| Capital Expenditures | -66.63M |
| Depreciation & Amortization | 61.40M |
| Net Borrowing | 101.24M |
| Free Cash Flow | 377.12M |
| FCF Per Share | $28.53 |
Margins
Gross margin is 32.38%, with operating and profit margins of 13.13% and 10.23%.
| Gross Margin | 32.38% |
| Operating Margin | 13.13% |
| Pretax Margin | 13.73% |
| Profit Margin | 10.23% |
| EBITDA Margin | 15.55% |
| EBIT Margin | 13.13% |
| FCF Margin | 14.84% |
Dividends & Yields
This stock pays an annual dividend of $2.40, which amounts to a dividend yield of 0.52%.
| Dividend Per Share | $2.40 |
| Dividend Yield | 0.52% |
| Dividend Growth (YoY) | 20.00% |
| Years of Dividend Growth | 17 |
| Payout Ratio | 13.11% |
| Buyback Yield | 5.66% |
| Shareholder Yield | 6.17% |
| Earnings Yield | 4.24% |
| FCF Yield | 6.16% |
Analyst Forecast
The average price target for Chemed is $446.50, which is -3.62% lower than the current price. The consensus rating is "Hold".
| Price Target | $446.50 |
| Price Target Difference | -3.62% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 6.01% |
| EPS Growth Forecast (3Y) | 10.21% |
Stock Splits
The last stock split was on May 12, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | May 12, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Chemed has an Altman Z-Score of 10.99 and a Piotroski F-Score of 5.
| Altman Z-Score | 10.99 |
| Piotroski F-Score | 5 |